MBTPS1 and myeloid sarcoma: Fingolimod (FTY720) was the first oral treatment for multiple sclerosis (MS), and its effective form, phosphorylated Fingolimod, shares a similar chemical scaffold as S1P and lacks receptor specificity (Supplementary Fig. 8).